Concepedia

F. Joseph Daugherty

FJ

Statistics

Publications

6

Citations

225

H-Index

6

Active since

2007

Affiliations

University of Nebraska at Omaha(Current)

F. Joseph Daugherty is an author at University of Nebraska at Omaha specializing in medicine, antisense rnas, and pharmacotherapy.

Publications per year

2007–2021

6

Publications

6

Bioactive A-Type Proanthocyanidins from <i>Cinnamomum cassia</i>

K. Brian Killday, Matthew H. Davey, Jan A. Gliński et al. · Journal of Natural Products · 2011 · 73 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

Can a concentrated cranberry extract prevent recurrent urinary tract infections in women? A pilot study

David T. Bailey, Carol Dalton, F. Joseph Daugherty et al. · Phytomedicine · 2007 · 64 citations

Medicine, Preventive Medicine, Urology +10

<i>TP53</i> suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients

Gisela Cáceres, Kathy L. McGraw, Bon Ham Yip et al. · Proceedings of the National Academy of Sciences · 2013 · 53 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia

Mark C. Lanasa, Patricia H. Davis, Michael Datto et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 15 citations

Medicine, Oncology, Pharmacotherapy +16

Final five-year median follow-up safety data from a prospective, randomized, placebo-controlled, single-blinded, multicenter, phase IIb study evaluating the use of HER2/neu peptide GP2 + GM-CSF vs. GM-CSF alone after adjuvant trastuzumab in HER2-positive women with operable breast cancer.

Snehal G. Patel, David B. McWilliams, Christine T. Fischette et al. · Journal of Clinical Oncology · 2021 · 10 citations

Medicine, Immunology, Oncology +14

1–5 of 6